Vasil Galat
Chief Executive & Scientific Officer ARTEC Biotech
Seminars
Wednesday 25th March 2026
Integrated Preclinical & Metabolic Optimization of NK Cells Derived from Pluripotent Stem Cells & Peripheral Blood
9:30 am
- Comparative characterization of iPSC- and peripheral blood–derived NK cells to define intrinsic phenotypic and metabolic differences
- Functional evaluation of cytotoxicity, persistence, and metabolic adaptability to reveal donor- and source-dependent performance variability
- Metabolic engineering strategies to enhance mitochondrial fitness, delay exhaustion, and improve next-generation NK cell efficacy
